hVIVO is a UK-based specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The surge in demand for challenge studies (illustrated by repeat, as well as more complex, contracts with big pharma and biotech) is driven by the economic and clinical arguments of testing drugs/vaccines in a controlled environment as opposed to the larger, more expensive and, arguably, more unpred ....
10 Jan 2023
hVIVO - Defensive growth in a challenging market (10 for 23 extract)
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
hVIVO - Defensive growth in a challenging market (10 for 23 extract)
hVIVO plc (HVO:LON) | 29.0 0 0.0% | Mkt Cap: 197.3m
- Published:
10 Jan 2023 -
Author:
Mark Brewer -
Pages:
6
hVIVO is a UK-based specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The surge in demand for challenge studies (illustrated by repeat, as well as more complex, contracts with big pharma and biotech) is driven by the economic and clinical arguments of testing drugs/vaccines in a controlled environment as opposed to the larger, more expensive and, arguably, more unpred ....